Clinical Trial Update: EPI-743 for Metabolism or Mitochondrial Disorders [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for EPI-743 in mitochondrial disease and related neurology/myopathy conditions shows completion with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitochondrial Disease
• Myopathy
• Neurology

Drugs mentioned

• EPI-743

Snippet

Sponsor: National Human Genome Research Institute (NHGRI) | Conditions: Mitochondrial Disease, Neurology | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-04-14